Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Study Title
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Teva Identifier
IXR-205-21-189
ClinicalTrials.gov Identifier
NCT00062504
Study Status
Terminated
Trial Condition(s)
Glioblastoma Multiforme|Anaplastic: Astrocytoma,Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma
Interventions
Drug: Talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years and older
Trial Duration
07/01/2003 - 04/01/2006
Phase
Phase 2

Study Type

Interventional